New biotech drug for diabetic foot ulcers
February 1998
You'll hear about a new biotech drug for diabetic foot ulcers...called Regranex (becaplermin gel).
It's being introduced now in the U.S...later in Canada.
It contains a platelet-derived growth factor to stimulate the growth of new tissue...resulting in a modest increase in healing.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive